  | Turner, M. C., Radzikowska, U., Ferastraoaru, D. E., Pascal, M., Wesseling, P., McCraw, A., BACKES, C., Bax, H. J., Bergmann, C., Bianchini, R., Cari, L., de Las Vecillas, L., Izquierdo, E., Lind-Holm Mogensen, F., MICHELUCCI, A., NAZAROV, P., NICLOU, S. P., Nocentini, G., OLLERT, M., ... Poli, A. (2024). AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus-A joint EAACI-EANO position paper. Allergy. doi:10.1111/all.15994  Peer Reviewed verified by ORBi |
 | Neirinckx, V., Hau, A.-C., Schuster, A., FRITAH, S., Tiemann, K., KLEIN, E., NAZAROV, P., Matagne, A., SZPAKOWSKA, M., MEYRATH, M. M. R., Chevigné, A., Schmidt, M. H. H., & NICLOU, S. P. (2024). The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein-protein interaction in glioblastoma. Neuro-Oncology Advances, 1 (1), 024. doi:10.1093/noajnl/vdz024 Peer Reviewed verified by ORBi |
Yabo, Y. A., Moreno-Sanchez, P. M., Pires-Afonso, Y., Kaoma, T., Nosirov, B., Scafidi, A., Ermini, L., Lipsa, A., Oudin, A., KYRIAKIS, D., GRZYB, K., POOVATHINGAL, S. K., Poli, A., Muller, A., TOTH, R., KLINK, B., BERCHEM, G. J. M. J., Berthold, C., HERTEL, F., ... GOLEBIEWSKA, A. (2023). Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/60199. doi:10.1101/2023.03.05.531162 |
 | RANDIC, T., MAGNI, S., PHILIPPIDOU, D., Margue, C., GRZYB, K., PREIS, J. R., WROBLEWSKA, J. P., NAZAROV, P., MITTELBRONN, M., FRAUENKNECHT, K., SKUPIN, A., & KREIS, S. (25 July 2023). Single-cell transcriptomics of NRAS-mutated melanoma transitioning to drug resistance reveals P2RX7 as an indicator of early drug response. Cell Reports, 42 (7), 112696. doi:10.1016/j.celrep.2023.112696 Peer Reviewed verified by ORBi |
 | Largeot, A., Klapp, V., Viry, E., Gonder, S., Fernandez Botana, I., Blomme, A., BENZARTI, M., Pierson, S., Duculty, C., Marttila, P., Wierz, M., Gargiulo, E., Pagano, G., An, N., El Hachem, N., Perez Hernandez, D., Chakraborty, S., Ysebaert, L., François, J.-H., ... MOUSSAY, E.*. (29 June 2023). Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL. Blood, 141 (26), 3166 - 3183. doi:10.1182/blood.2022017839 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Poli, A., Oudin, A., Muller, A., Salvato, I., Scafidi, A., Hunewald, O., Domingues, O., NAZAROV, P., Puard, V., Baus, V., AZUAJE, F., DITTMAR, G., ZIMMER, J., MICHEL, T., MICHELUCCI, A., NICLOU, S. P., & OLLERT, M. (March 2023). Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice. Allergy, 78 (3), 682-696. doi:10.1111/all.15545 Peer Reviewed verified by ORBi |
 | Gargiulo, E., Viry, E., Morande, P. E., Largeot, A., Gonder, S., Xian, F., Ioannou, N., BENZARTI, M., Borgmann, F. B. K., MITTELBRONN, M., DITTMAR, G., NAZAROV, P., MEISER, J., Stamatopoulos, B., Ramsay, A. G., MOUSSAY, E.* , & PAGGETTI, J.*. (2023). Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses. Blood Cancer Discovery, 4 (1), 54 - 77. doi:10.1158/2643-3230.BCD-22-0029 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Diaz-Uriarte, R., Gómez de Lope, E., Giugno, R., Fröhlich, H., Nazarov, P., Nepomuceno-Chamorro, I. A., Rauschenberger, A., & Glaab, E. (2022). Ten Quick Tips for Biomarker Discovery and Validation Analyses Using Machine Learning. PLoS Computational Biology, 18 (8), 1010357. doi:10.1371/journal.pcbi.1010357 Peer Reviewed verified by ORBi |
 | Sharma, A. B., Erasimus, H., Pinto, L., Caron, M.-C., Gopaul, D., Peterlini, T., Neumann, K., NAZAROV, P., FRITAH, S., KLINK, B., Herold-Mende, C. C., NICLOU, S. P., Pasero, P., Calsou, P., Masson, J.-Y., Britton, S., & Van Dyck, E. (27 September 2021). XAB2 promotes Ku eviction from single-ended DNA double-strand breaks independently of the ATM kinase. Nucleic Acids Research, 49 (17), 9906-9925. doi:10.1093/nar/gkab785 Peer Reviewed verified by ORBi |
 | Schuster, A., KLEIN, E., Neirinckx, V., Knudsen, A. M., Fabian, C., Hau, A.-C., Dieterle, M., Oudin, A., NAZAROV, P., GOLEBIEWSKA, A., Muller, A., Perez-Hernandez, D., Rodius, S., DITTMAR, G., Bjerkvig, R., Herold-Mende, C., KLINK, B., Kristensen, B. W., & NICLOU, S. P. (11 December 2020). AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion. Nature Communications, 11 (1), 6366. doi:10.1038/s41467-020-20029-y Peer Reviewed verified by ORBi |
 | GOBIN, M., NAZAROV, P., Warta, R., Timmer, M., Reifenberger, G., Felsberg, J., Vallar, L., Chalmers, A. J., Herold-Mende, C. C., Goldbrunner, R., NICLOU, S. P., & Van Dyck, E. (15 March 2019). A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical Implications. Cancer Research, 79 (6), 1226-1238. doi:10.1158/0008-5472.CAN-18-2076 Peer Reviewed verified by ORBi |
 | AZUAJE, F., Kaoma, T., Jeanty, C., NAZAROV, P., Muller, A., Kim, S.-Y., DITTMAR, G., GOLEBIEWSKA, A., & NICLOU, S. P. (2018). Hub genes in a pan-cancer co-expression network show potential for predicting drug responses. F1000Research, 7, 1906. doi:10.12688/f1000research.17149.2 Peer Reviewed verified by ORBi |